Table 4:
CERs of each group of OLPDs
| Mean CER ± SD | CER Range | P Value | |
|---|---|---|---|
| Orbital lymphoma (n = 27) | 1.70 ± 0.25 | 1.27–2.24 | P = .0096a |
| MALT lymphoma (n = 20) | 1.27–2.24 | ||
| DLBCL (n = 3) | 1.36–1.71 | ||
| Follicular lymphoma (n = 3) | 1.76–1.94 | ||
| Mantle cell lymphoma (n = 1) | 1.55 | ||
| Benign OLPDs (n = 15) | 2.07 ± 0.46 | 1.27–3.03 | |
| IgG4-related ophthalmic disease (n = 11) | 1.27–3.03 | ||
| RLH (n = 4) | 1.66–2.14 |
a
There were significant differences in CER between the 2 groups. SD indicates standard deviation; DLBCL, diffuse large B-cell lymphoma; RLH, reactive lymphoid hyperplasia.